Parasternal Nerve Block Using Bupivacaine for Postoperative Analgesia in Children Undergoing Cardiac Surgery
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
All pediatric patients who undergo cardiac surgery require analgesic medications for
postoperative pain control and many require sedation to facilitate comfort with cares.
Parasternal infiltration of local anesthetic for nerve blocks is a simple option to
postoperative analgesia. The investigators hypothesize that Bupivacaine, a parasternal nerve
block administered in pediatric patients undergoing cardiac surgery will reduce the
requirement of Opioids and other pain medications as well as decrease postoperative pain
scores. This is a prospective, double-blind, randomized controlled trial. Subjects are
randomized to receive either 0.25% Bupivacaine or normal saline following their
cardiothoracic surgery.